Researchers have advised asthma patients to continue their medication for long-term benefits even if they have fewer symptoms.
The study led by researchers in Childhood Asthma Management Program (CAMP) has shown that although patients had fewer symptoms five years after stopping the daily medication, they are primed to an attack if they got a bad cold or during weather change.
During the study, more than 1,000 children age 5-12 were treated for mild to moderate asthma over more than four years and followed up for nearly five years after the end of the trial.
They were divided into three groups: one received twice-daily budesonide, an inhaled corticosteroid medication; one received nedocromil, an inhaled non-steroid medication; and one group received a placebo. All children received albuterol, a bronchodilator, and oral corticosteroids as needed for asthma symptoms.
They found that the children, now in their late teens, who took the medications during the trial showed no difference in their asthma control compared with the children who received the placebo.